Search Results - P Roncucci
- Showing 1 - 1 results of 1
-
1
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol by Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, P Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia
Published 2020Artigo
Search Tools:
Related Subjects
Acute respiratory distress
Alternative medicine
Bone marrow
Coronavirus
Coronavirus disease 2019 (COVID-19)
Disease
Immunology
Infectious disease (medical specialty)
Intensive care medicine
Internal medicine
Lung
Medicine
Myelofibrosis
Pathology
Protocol (science)
Ruxolitinib
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)